Quick Summary Partnership Focus: Nvidia, Amgen’s deCode Genetics, and Recursion Pharmaceuticals collaborate to harness AI in drug discovery. Platform: Nvidia’s BioNeMo platform will be used
Quick Summary Device: Butterfly Network’s iQ3 handheld ultrasound FDA Clearance: Cleared as a point-of-care ultrasound device, featuring advanced 3D capabilities and AI-powered imaging modes. Technological
Quick Summary Partnership: BD (Becton, Dickinson and Company) teams up with Ypsomed to develop advanced self-injection systems. Focus: Enhancing patient experience for high-viscosity biologics often
Quick Summary Trial Outcome: Boston Scientific’s Acurate neo2 transcatheter aortic valve replacement (TAVR) system missed its primary endpoint in a critical trial. Comparison Results: Acurate
Quick Summary Device Count: Over 950 AI-enabled medical devices have been cleared by the FDA, with radiology devices comprising the majority. FDA Pathway: Most devices
Quick Summary Contract Value: $1.24 billion—the largest single contract for Samsung Biologics to date. Client: An Asia-based pharmaceutical company. Production Location: Songdo, South Korea, at
